Vialwirebiotech, curated
November 21, 2026, 8:26 AM
October 16, 2026
- 9:00 AM · BioWorld9:00 AMNIH award supports Expression Therapeutics’ ET-501 — BioWorld
- 9:00 AM · BioWorld9:00 AMEikon Therapeutics submits IND for AR antagonist EIK-1006 — BioWorld
- 9:00 AM · BioWorld9:00 AMEstuary Biotherapeutics launches with targeted gene therapies for ADPKD — BioWorld
- 9:00 AM · BioWorld9:00 AMChina NMPA clears CSPC’s solid tumor programs to enter clinic — BioWorld
- 6:59 AM · Pharmaceutical Technology6:59 AMOrbiMed raises $3bn to back global life science players — Pharmaceutical Technology
- 6:09 AM · Pharmaceutical Technology6:09 AMActa Pharmaceuticals raises $24m for Alzheimer’s therapies — Pharmaceutical Technology
- 6:00 AM · Drug Discovery World6:00 AMBioNTech’s mRNA immunotherapy fails to meet primary endpoint — Drug Discovery World
- 4:14 AM · Pharmaceutical Technology4:14 AMTranscripta Bio, Mayo Clinic join force on ALS therapies — Pharmaceutical Technology
October 15, 2026
- 12:00 PM · BioWorld12:00 PMAI biopharma Iambic prices $150M IPO — BioWorld
- 12:00 PM · BioWorld12:00 PMInsitro’s Virtual Human attracts $1.5B MASH deal with Astrazeneca — BioWorld
- 11:55 AM · BioPharma Dive11:55 AMBelgian startup revives Galapagos CAR-T research — BioPharma Dive
- 11:43 AM · STAT News11:43 AMSTAT+: Verastem’s KRAS inhibitor shows promise in pancreatic cancer — STAT News
- 9:00 AM · BioWorld9:00 AMAltay Therapeutics raises funds to advance DUX4 inhibitor DX-5057 — BioWorld
- 9:00 AM · BioWorld9:00 AMFinancing at Omass Therapeutics to support lead program — BioWorld
- 9:00 AM · BioWorld9:00 AMGalibra advances GAL-005 for SSADH deficiency — BioWorld
- 9:00 AM · BioWorld9:00 AMAtalanta, now Arexera Therapeutics, reports pipeline update — BioWorld
- 7:00 AM · Drug Discovery World7:00 AMSapreme shares “unprecedented” preclinical data for Duchenne candidate — Drug Discovery World
- 6:00 AM · Drug Discovery World6:00 AMQIAGEN expands AI-powered bioinformatics for research and drug discovery — Drug Discovery World
- 5:59 AM · Pharmaceutical Technology5:59 AMQCi and INmune Bio partner to study XPro in Alzheimer’s — Pharmaceutical Technology
- 5:42 AM · Pharmaceutical Technology5:42 AMImmunityBio’s bladder cancer drug, Anktiva lands US label expansion — Pharmaceutical Technology
- 5:00 AM · Drug Discovery World5:00 AMPopulate appoints Director of Science and Innovation — Drug Discovery World
- 3:57 AM · Pharmaceutical Technology3:57 AMAlentis and PinotBio partner to develop claudin-1 oncology ADCs — Pharmaceutical Technology
October 14, 2026
- 8:01 PM · STAT News8:01 PMCompass Pathways CEO: Psychedelics company will ‘go slow before we go fast’ — STAT News
- 7:00 PM · TechCrunch7:00 PMIntero Biosystems wants drugmakers to test on mini human intestines, not animals — TechCrunch
- 4:16 PM · STAT News
- 12:00 PM · BioWorld12:00 PMFDA rolls out initiative to address rare disease challenges — BioWorld
- 12:00 PM · BioWorld12:00 PMVir partners with Gilead in $1.8B+ deal for T-cell engagers — BioWorld
- 12:00 PM · BioWorld12:00 PMZealand in $1.2B+ protein drug deal with AI specialist Generate — BioWorld
- 11:54 AM · BioPharma Dive11:54 AMExperimental Arrowhead RNAi drug hints at Alzheimer’s benefit — BioPharma Dive